Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-14-016991)

Filing Details

Accession Number:: 0001179110-14-016991
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-24 17:49:18
Reporting Period:: 2014-11-20

Filing Date:: 2014-11-24
Accepted Time:: 2014-11-24 17:49:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274057	Hospira Inc	HSP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601509	Royce Bedward	C/O Hospira, Inc. 275 North Field Drive Lake Forest IL 60045	Svp, General Counsel And Sec'y	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-20	2,333	$43.18	25,432	No	4	M	Direct
Common Stock	Disposition	2014-11-20	2,133	$58.67	23,299	No	4	S	Direct
Common Stock	Disposition	2014-11-20	200	$58.69	23,099	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2014-11-20	2,333	$0.00	2,333	$43.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,667		2015-03-05	No	4	M	Direct

Footnotes

Exercise of a derivative security exempted pursuant to Rule 16b-3.
The stock options vest in three equal annual installments on March 6, 2009, 2010, and 2011. The exercise price of $43.18 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on March 5, 2015.